BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 20600462)

  • 21. [Glucocorticoids and aetiopathogenesis of depression].
    Viinamäki H; Lehto SM; Palvimo JJ; Harvima I; Valkonen-Korhonen M; Koivumaa-Honkanen H; Hintikka J; Kirsi H; Niskanen L
    Duodecim; 2012; 128(10):1022-9. PubMed ID: 22724317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune system, depression and the action of antidepressants.
    Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):767-80. PubMed ID: 11383977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research update: neurogenesis in adult brain and neuropsychiatric disorders.
    Elder GA; De Gasperi R; Gama Sosa MA
    Mt Sinai J Med; 2006 Nov; 73(7):931-40. PubMed ID: 17195878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurogenesis and depression: etiology or epiphenomenon?
    Henn FA; Vollmayr B
    Biol Psychiatry; 2004 Aug; 56(3):146-50. PubMed ID: 15271582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory mechanisms in major depressive disorder.
    Raedler TJ
    Curr Opin Psychiatry; 2011 Nov; 24(6):519-25. PubMed ID: 21897249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids.
    Grimble RF; Tappia PS
    Z Ernahrungswiss; 1998; 37 Suppl 1():57-65. PubMed ID: 9558730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is depression an inflammatory condition? A review of available evidence.
    Hashmi AM; Butt Z; Umair M
    J Pak Med Assoc; 2013 Jul; 63(7):899-906. PubMed ID: 23901717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response.
    Janssen DG; Caniato RN; Verster JC; Baune BT
    Hum Psychopharmacol; 2010 Apr; 25(3):201-15. PubMed ID: 20373471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in animal models of depression and antidepressant response.
    Dalla C; Pitychoutis PM; Kokras N; Papadopoulou-Daifoti Z
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):226-33. PubMed ID: 20050844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurobiological mechanisms of depression and antidepressant therapy].
    Shishkina GT; Dygalo NN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids, cytokines and brain abnormalities in depression.
    Zunszain PA; Anacker C; Cattaneo A; Carvalho LA; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):722-9. PubMed ID: 20406665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The essential fatty acids omega-6 and omega-3: from their discovery to their use in therapy].
    Caramia G
    Minerva Pediatr; 2008 Apr; 60(2):219-33. PubMed ID: 18449139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune modulation of learning, memory, neural plasticity and neurogenesis.
    Yirmiya R; Goshen I
    Brain Behav Immun; 2011 Feb; 25(2):181-213. PubMed ID: 20970492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPA and immune axes in stress: involvement of the serotonergic system.
    Leonard BE
    Neuroimmunomodulation; 2006; 13(5-6):268-76. PubMed ID: 17709948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.
    Kim HJ; Kim W; Kong SY
    Arch Pharm Res; 2013 Nov; 36(11):1279-90. PubMed ID: 24129616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
    Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):784-94. PubMed ID: 20609377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of inflammatory cytokines on the aetiopathogenesis of depression.
    Makhija K; Karunakaran S
    Aust N Z J Psychiatry; 2013 Sep; 47(9):828-39. PubMed ID: 23636913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
    Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.